| 000 | 01455 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513135604.0 | ||
| 264 | 0 | _c19980319 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0361-8609 | ||
| 024 | 7 |
_a10.1002/(sici)1096-8652(199803)57:3<193::aid-ajh2>3.0.co;2-q _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeinstock, D M | |
| 245 | 0 | 0 |
_aComparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cMar 1998 |
||
| 300 |
_a193-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aFactor VII _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPeptide Fragments _xurine |
| 650 | 0 | 4 |
_aProtein Precursors _xurine |
| 650 | 0 | 4 |
_aProthrombin _xmetabolism |
| 650 | 0 | 4 | _aProthrombin Time |
| 650 | 0 | 4 |
_aThrombosis _xblood |
| 650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
| 700 | 1 | _aChang, P | |
| 700 | 1 | _aAronson, D L | |
| 700 | 1 | _aKessler, C M | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 57 _gno. 3 _gp. 193-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1096-8652(199803)57:3<193::aid-ajh2>3.0.co;2-q _zAvailable from publisher's website |
| 999 |
_c9463477 _d9463477 |
||